Meiji Yasuda Asset Management CO Ltd. Roivant Sciences Ltd. Transaction History
Meiji Yasuda Asset Management CO Ltd.
- $2.56 Billion
- Q4 2024
A detailed history of Meiji Yasuda Asset Management CO Ltd. transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Meiji Yasuda Asset Management CO Ltd. holds 10,481 shares of ROIV stock, worth $112,146. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,481
Previous 10,736
2.38%
Holding current value
$112,146
Previous $123,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ROIV
# of Institutions
332Shares Held
505MCall Options Held
573KPut Options Held
739K-
Qvt Financial LP New York, NY65.8MShares$704 Million76.3% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X062.1MShares$664 Million6.45% of portfolio
-
Viking Global Investors LP47.8MShares$512 Million1.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA44.1MShares$472 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$378 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.54B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...